420 related articles for article (PubMed ID: 6980948)
1. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
Abo T; Cooper MD; Balch CM
J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
Abo T; Miller CA; Balch CM
Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709
[TBL] [Abstract][Full Text] [Related]
3. In vitro propagation of cultured human natural killer cells expressing the HNK-1 differentiation antigen and spontaneous cytotoxic function.
Abo T; Balch CM
Eur J Immunol; 1983 May; 13(5):383-9. PubMed ID: 6406236
[TBL] [Abstract][Full Text] [Related]
4. Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells.
Abo T; Balch CM
J Immunol; 1982 Oct; 129(4):1758-61. PubMed ID: 7108226
[TBL] [Abstract][Full Text] [Related]
5. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.
Abo T; Miller CA; Gartland GL; Balch CM
J Exp Med; 1983 Jan; 157(1):273-84. PubMed ID: 6848618
[TBL] [Abstract][Full Text] [Related]
6. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
Rumpold H; Kraft D; Gastl G; Huber C
Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human K cells by surface antigens and morphology at the single cell level.
Wåhlin B; Perlmann P
J Immunol; 1983 Nov; 131(5):2340-7. PubMed ID: 6226741
[TBL] [Abstract][Full Text] [Related]
8. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
Tilden AB; Abo T; Balch CM
J Immunol; 1983 Mar; 130(3):1171-5. PubMed ID: 6218202
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
[TBL] [Abstract][Full Text] [Related]
10. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
11. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).
Abo T; Balch CM
J Immunol; 1981 Sep; 127(3):1024-9. PubMed ID: 6790607
[TBL] [Abstract][Full Text] [Related]
12. The analysis of expanded cells from patients with lymphoproliferative disorders of granular lymphocytes may help to clarify the NK cell differentiation.
Zambello R; Chisesi T; De Rossi G; Pandolfi F; Trentin L; Vespignani M; Luciani M; Cafaro A; Agostini C; Martelli M
J Clin Lab Immunol; 1986 Jul; 20(3):107-11. PubMed ID: 3746877
[TBL] [Abstract][Full Text] [Related]
13. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes.
Rumpold H; Kraft D; Obexer G; Böck G; Gebhart W
J Immunol; 1982 Oct; 129(4):1458-64. PubMed ID: 6180009
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities.
Lopez-Botet M; Moretta L
J Immunol; 1985 Apr; 134(4):2299-304. PubMed ID: 3919089
[TBL] [Abstract][Full Text] [Related]
17. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
Tilden AB; Itoh K; Balch CM
J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characteristics of human natural killer cells.
Perussia B; London L; Trinchieri G
Biomed Pharmacother; 1985; 39(1):13-8. PubMed ID: 3875369
[TBL] [Abstract][Full Text] [Related]
19. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
[TBL] [Abstract][Full Text] [Related]
20. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
